ConductScience.org, home

Gene10331

B3GNT3: UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3

Cite this record

ConductScience Library. B3GNT3: UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3. Genes, record 10331. Release gene-search-2026-11-13-0.2.1, 13 Nov 2026. https://conductscience.org/library/genes/10331

FollowSave as evidenceDownload JSON
Sources
13 sources
Release
gene-search-2026-11-13-0.2.1

Gene

Symbol
B3GNT3
HGNC
Name
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3
HGNC
NCBI Gene ID
10331
NCBI Gene
HGNC ID
HGNC:13528
HGNC
Ensembl
ENSG00000179913
NCBI Gene
Aliases
B3GAL-T8, B3GN-T3, B3GNT-3, HP10328, TMEM3, beta3Gn-T3
NCBI Gene
Type
protein-coding
NCBI Gene

Proteins1

Reviewed human proteins whose Swiss-Prot entry states the gene.

UniProt entryProteinLengthStructuresGene stated in
Q9Y2A9N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase 33720Ensembl, GeneID, HGNC

Source UniProt

Download CSV of proteins

Patents115

Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.

PublicationPublishedSEQ ID NOProteinSource
US 20260201011 A12026-07-161334Q9Y2A9Espacenet
US 20260201011 A12026-07-161335Q9Y2A9Espacenet
US 20260193644 A12026-07-095003Q9Y2A9Espacenet
US 20260139247 A12026-05-215564Q9Y2A9Espacenet
US 20260125700 A12026-05-071334Q9Y2A9Espacenet
US 20260125700 A12026-05-071335Q9Y2A9Espacenet
US 20260125701 A12026-05-071334Q9Y2A9Espacenet
US 20260125701 A12026-05-071335Q9Y2A9Espacenet
JP 2026004568 A2026-01-1469186Q9Y2A9Espacenet
EP 4641201 A22025-10-295003Q9Y2A9Espacenet

See all 115 patentsDownload CSV of patents

NIH grants216

NIH grants whose papers are about the gene, through NIH's grant-paper links.

GrantTitleB3GNT3 papersNewest fiscal year
P30CA036727Buffett Cancer Center Support Grant32025
P30CA016087Cancer Center Support Grant22025
P30CA016672Cancer Center Support Grant22025
R35GM119850Unraveling the mammalian secretory pathway through systems biology and algorithm development22025
F30OD031914MicroRNA-375 regulation of enteroendocrine cell biology in diet-induced obesity and bariatric surgery12025
P30AG072946University of Kentucky Alzheimer's Disease Research Center12025
P30CA008748Cancer Center Support Grant12025
P30CA013330Cancer Center Support Grant12025
P30CA016056Roswell Park Cancer Center Support Grant12025
P30CA016058Cancer Center Support Grant12025

Source NIH's project files

See all 216 nih grantsDownload CSV of nih grants

Papers309

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

TitleJournalYearPMIDFound bySource
B3GALT5 regulates renal A/B antigen levels: a determinant of prognosis and rejection in ABO-incompatible kidney transplantation.J Glob Health202642788334PubTator, text miningPubMed
Distinct glycosyltransferase expression governs organ-specific survival in pancreatic cancer metastasis.Oncogene202642533113PubTator, text miningPubMed
Oxymatrine Synergizes with 5-fluorouracil to Inhibit the Proliferation of A549 Cells by Targeting APE1.Curr Med Chem202642522309PubTator, text miningPubMed
Association of B3GNT3 Expression with Tumour Stage and Lymph Node Metastasis in Colon Adenocarcinoma.Int J Mol Sci202642511615PubTator, text miningPubMed
Integrated Bioinformatics Analysis of Human Transcriptomic Data Identifies Three Key Diagnostic and Prognostic Biomarkers in Lung Adenocarcinoma.J Vis Exp202642475443PubTator, text miningPubMed
Evaluation of the impact of glycolysis-related gene signatures on prognosis and therapeutic targeting in lung adenocarcinoma.Cytotechnology202641987806PubTator, text miningPubMed
Construction and validation of a prognostic model for lung adenocarcinoma based on necrotic cell death triggered by sodium overload-related coexpressed genes.Front Genet202641847125PubTator, text miningPubMed
B3GNT3 facilitates NFKB2 processing and non-canonical NF-κB activation to drive lung adenocarcinoma progression.Cell Oncol (Dordr)202641838238PubTator, text miningPubMed
Strategies to target PD-1/PD-L1 in the tumor microenvironment.Cell Oncol (Dordr)202641784760PubTator, text miningPubMed
Rare-variant burden across lysosomal genes implicates sialylation and ganglioside metabolism in Parkinson's disease.medRxiv202641757160PubTator, text miningPubMed

See all 309 papersDownload CSV of papers

None in this release

  • Drugs
  • Trials

Sources 13

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
  • USPTO's sequence listingsPublic domain in the US. Source: United States Patent and Trademark Office, www.uspto.gov
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
  • USPTO's sequence listingsUSPTO's sequence listings of patents and published applications, from its bulk data files. No license named for the files. USPTO's terms say "most government-produced materials appearing on this website are not subject to copyright restrictions within the United States and are therefore in the public domain", and ask that USPTO be given appropriate acknowledgement ("Source: United States Patent and Trademark Office, www.uspto.gov"). USPTO does not endorse ConductScience or this release. Read on 12 Nov 2026 at https://www.uspto.gov/terms-use-uspto-websites

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

Source: United States Patent and Trademark Office, www.uspto.gov. USPTO does not endorse ConductScience or this database.

For software

Read this gene from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/genes/v1/10331

GET https://conductscience.org/api/genes/v1/10331/patents?page=2